ChemoCentryx: Q1 Earnings Insights

ChemoCentryx CCXI reported its Q1 earnings results on Thursday, May 5, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

ChemoCentryx missed estimated earnings by 83.33%, reporting an EPS of $-0.55 versus an estimate of $-0.3.

Revenue was down $4.89 million from the same period last year.

Last quarter the company missed on EPS by $0.08 which was followed by a 16.67% drop in the share price the next day.

Here's a look at ChemoCentryx's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.50	-0.45	-0.54	-0.40
EPS Actual	-0.58	-0.32	-0.56	-0.43
Revenue Estimate	11.62M	13.48M	4.85M	7.93M
Revenue Actual	2.31M	17.74M	1.81M	10.35M

To track all earnings releases for ChemoCentryx visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.